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SUMMARY
It is widely accepted that features such as pI, length, molecular mass and amino acid 
(AA) sequence have a significant influence on protein solubility. Here, we mainly focused 
on AA composition and explored those that most affected the soluble expression level of 
human serum albumin (HSA) domain antibody (dAb). The soluble expression and sequence 
of 65 dAb variants were analysed using clustering and linear modelling. Certain AAs sig-
nificantly affected the soluble expression level of dAb, with the specific AA combinations 
being (S, R, N, D, Q), (G, R, C, N, S) and (R, S, G); these combinations respectively affected the 
dAb expression level in the broth supernatant, the level in the pellet lysate and total soluble 
dAb. Among the 20 AAs, R displayed a negative influence on the soluble expression level, 
whereas G and S showed positive effects. A linear model was built to predict the soluble 
expression level from the sequence; this model had a prediction accuracy of 80 %. In sum-
mary, increasing the content of polar AAs, especially G and S, and decreasing the content 
of R, was helpful to improve the soluble expression level of HSA dAb.
Key words: domain antibody (dAb), Escherichia coli, heterologous protein soluble expres-
sion, linear modelling, primary structure
INTRODUCTION
Given the outstanding advantages of Escherichia coli, including fast growth, inexpensive 
culturing, high-density cultivation, and simple genetic manipulation, it has been suggested 
that E. coli should be the first host tried for expression of any protein (1). However, most pro-
teins from eukaryotes have low solubility when expressed in E. coli. For instance, over 80 % 
of non-membrane proteins were unsuitable for structural studies and over 90 % of potential 
pharmaceutical proteins were terminated at an early stage of clinical development because 
of their low solubility when expressed in E. coli (2). Several strategies have been used to in-
crease protein production and solubility, for example altering expression system elements 
(3,4) and optimizing culture conditions (5). These efforts are time-consuming, costly and usu-
ally difficult (6) because of a lack of understanding of the correlation between the effect of the 
expression system components and the characteristics of the expressed protein.
Interestingly, it has been found that primary structure features have a great impact on 
protein overexpression in E. coli (7,8). Several prediction models have been established (6,9), 
such as the Harrison prediction model (10), multiple linear regression (MLR) model (11), sol-
ubility index-based model (12), support vector machine-based model (13,14), PROSO model 
(15), SOLpro model (16), cc SOL model (17) and PROSO II model (18). These bioinformatics 
models can significantly reduce trial and error procedures involved in optimization of expres-
sion systems to increase the soluble expression level of heterologous proteins. However, there 
has been limited application of these prediction models, partly because of the significant dif-
ferences among the proteins chosen for building them and also because of the adoption of 
inconsistent culture conditions for expression of proteins (6,8,9).
Domain antibodies (dAbs), which consist of only variable regions of heavy (V
H
) or light 
(V
L
) chains (19), have simple tertiary structures (Fig. 1; 20,21), thus it is helpful to focus on 
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the features that influence dAb expression level on prima-
ry structures. There are three hypervariable regions in dAbs, 
namely complementarity-determining regions (CDRs) I, II and 
III, where sequence variability is concentrated to determine 
the antigen-binding activity of an antibody (22). Small vari-
ations of amino acids (AAs) within a short region leading to 
clear variation in soluble expression level, ease of expression 
in E. coli (23), and a simple tertiary structure make dAbs an 
ideal model molecule to investigate the connections between 
primary structure features and the corresponding soluble pro-
tein expression levels.
In this study, a single expression system was used to ex-
press multiple human serum albumin (HSA) dAb variants with 
identical culture and detection conditions, to ensure that no 
other factors such as culture conditions affect the dAb expres-
sion. Clustering and stepwise regression were used to explore 
the correlation between AA sequences and soluble expres-
sion levels of HSA dAbs, aiming at building a linear regres-
sion model to predict the soluble expression level of HSA dAb 
based simply on its AA sequence. Such a model may act as a 
general guide for site-directed mutagenesis of HSA dAbs or 
other similar dAbs/Abs to improve the soluble expression lev-
els, which benefits further studies such as interaction mecha-
nism and structure research.
MATERIALS AND METHODS
Random mutation of AAs in the CDRs of the original HSA 
dAb
Five amino acids (AAs) were chosen in each complemen-
tarity-determining region (CDR) (there are three CDRs, so 
15 AAs in total were chosen) to mutate randomly into other 
AAs, in this way we generated a mutation library consisting 
of about 107 samples. These samples varied little in pI and 
molecular mass and had the same length, thus it was helpful 
to focus on the variables of AA composition. Then, 65 mu-
tated HSA dAbs excluding terminator mutants (AUA, CCU, 
CCC, AGA and AGG) or sequential repeat mutants were cho-
sen randomly as experimental subjects and 10 were chosen 
as verification subjects. These mutated sequences are listed 
in Table 1.
Production of recombinant dAb expressing E. coli strains
The dAb fragments were cloned into vector pBY (an ef-
ficient expression vector constructed by a coworker in our 
lab) and introduced into E. coli strain BL21(DE3). The trans-
formed cells were plated onto Luria-Bertani (LB) agar plates 
(Solarbio® Life Sciences, Beijing, PR China) and incubated at 
37 °C overnight. After that, single colonies were selected 
and inoculated into 25 mL of LB medium (containing 15 μg/
mL of tetracycline (Shanghai Shenggong Co. Ltd., Shang-
hai, PR China) in 250-mL flasks and incubated at 37 °C for 7 
h with shaking at 230 rpm. Stock solutions were prepared 
by mixing 500 μL of culture with 500 μL of 20 % glycerol 
(Shanghai Hushi Laboratorial Equipment Co. Ltd., Shang-
hai, PR China) solution in 1.5-mL tubes, and the cells were 
stored at −80 °C.
Cultivation of E. coli strains
Cultivation can be divided into three phases: seed cul-
ture, growth and induction phase. Forty-eight square mul-
tititer plates (48-MTP; Thermo Fisher Scientific, Shanghai, PR 
China) were used to culture the 66 strains (65 mutated strains 
and a control strain) to achieve parallel fermentation. In the 
seed culture phase, 2 mL of LB medium containing 15 μg/mL 
of tetracycline were added into each well of the 48-MTP. After 
inoculation with 20 μL of stock cell solution, 48-MTPs were 
incubated in a shaker at 230 rpm and 30 °C for 16 h. In the 
growth phase, the seed solutions were transferred to fresh 
48-MTPs containing 2 mL of Terrific Broth/Super Broth (TB/
SB; Solarbio® Life Sciences) medium with 15 μg/mL of tetra-
cycline and cultured under the same conditions as described 
above. The inoculum volume was calculated by the following 




where V is the volume, 0.05 is the initial absorbance (A) at 595 
nm and A is the absorbance of seed culture solution.
Seven hours after the second inoculation, isopro-
pyl-β-d-thiogalactoside (IPTG; Solarbio® Life Sciences) was 
added to each well to a final concentration of 0.1 mM and 
the culture temperature was lowered to 23 °C simultane-
ously. The induction phase lasted for 16 h. After centrifuga-
tion of the culture broth at 6000×g (centrifuge model Sor-
vall ST 16R; Thermo Fisher Scientific, Shanghai, PR China), 
the supernatants were collected, the cell pellets were resus-
pended in phosphate-buffered saline (PBS; Shanghai Hushi 
Fig. 1. 3D structure of human serum albumin (HSA) domain antibody 
(dAb) used in this study. 3D structure was obtained from SWISS-MOD-
EL (20) and complementarity-determining regions (CDRs) were dec-
orated in three different colours (red, yellow and blue) by PyMOL (21)
Food Technol. Biotechnol. 56 (1) 101-109 (2018)
103January-March 2018 | Vol. 56 | No. 1 
Laboratorial Equipment Co. Ltd) and lysed using Precellys 
24 (Bertin Technologies, Paris, France), and then superna-
tants were collected.
The whole process of cultivation was repeated six times; 
batches with small deviation of dAb production by control 
strain were chosen for further analysis, and in this way, par-
allel operations were guaranteed.
Detection and quantification of soluble dAb protein and 
total protein
Two amounts of soluble expression of dAbs were meas-
ured by direct ELISA, i.e. soluble dAbs in broth supernatant 
and in pellet lysate supernatant. Flat-bottomed 96-well plates 
(Thermo Fisher Scientific) were first coated with 50 μL of su-
pernatant. After blocking with 5 % non-fat milk in PBS with 
Table 1. Mutation results of 15 animo acids in complementarity-determining regions (CDRs) of human serum albumin (HSA) domain antibodies 
(dAb)
No. CDR1 CDR2 CDR3 No. CDR1 CDR2 CDR3
1 SQPHA WLE-K QFKHS 34 QYKDG LLTHN RNGAN
2 KGNLR CCSLR PASTS 35 RTPQM WNVNV KGGVL
3 RQYCP AGVST T-FMG 36 QQLTL QSWTL FCALL
4 ----- IAYSA QFYWE 37 -KNKP RRASI PVSGN
5 ISNHW ERVSN QKFGV 38 LPKRL GFLWI NKLWQ
6 YTPLY FWR-Y MHLML 39 DPREP VMVKW P-YDV
7 PKFCL SFEGG KDNYL 40 NNNRR PRYLF NLHSA
8 SRCVH SPA-G NNYHK 41 LDKNA VLLIC FGWPV
9 RGPLS WTTVL DK-FT 42 DVCFK LT-AS WATSN
10 SYIVP RAVL- NLGYL 43 WTLCS VDTAR FL-RS
11 -PRHL CGMTS WGISP 44 ISKST IPYCQ NILQL
12 TVPYR ALTIG -KSMS 45 KYHQS RLLLE KLTLL
13 PSSIY CCVDV WRYEA 46 TIWKY GFVLC QINEK
14 RLCPY NSLGL SRCHY 47 SVGAD VSVAP STR-N
15 TP-VT VSQ-Q KTGPL 48 YDIGH QRSRR AADSD
16 RWSFR RTTQN VNPMR 49 ----- ----- KLQCT
17 SGLPT FTWLI ETPAL 50 GGLSL GWLTT IMT-K
18 ----- VNG-T QFTGS 51 RANYN RLGAA HNMLQ
19 YYLFS EFIR- SCALA 52 TAVT- TA-LP DEPMR
20 -RPGL ASALA SAVRA 53 QL-F- SWLAS VDRAA
21 QNRWL -GLSS -K-CP 54 EASPR VNVVP GLNMR
22 NTPFL GNGLV VNNNN 55 GA-VG ----- GSVCN
23 FVITQ MLRQT -AYVA 56 SQSSQ PFLFF CYLPL
24 AVGTW DDARS MAQLA 57 CRLTC LRLQH VNLQE
25 AHNAE PLSLP SMSCF 58 NRNTG GFLWI NKLWQ
26 SILTG QNCWC -RNHA 59 WCEPS SAAQS NSFFE
27 VPHGG FRRVN RVSSK 60 ALGCC FHDSR SQNTV
28 TIQQA CDL-T VCTGW 61 -YRHQ YTFWT YGCSK
29 YTPPR TG--N SFWNP 62 CTKTL ----- VLAVM
30 DIAGN RV-HL QRMKK 63 GTITQ GTSTT -TYLT
31 TPESR C-SES DGQSD 64 SHYNQ APVES -VNGL
32 ILFNL ----- SCMAS 65 NHAVK -PIYL KINTP
33 LRSLE D-TSV MMDLW Ori HETMV HIPPD LPKRG
V1 SRKWC DF-FT RVLGW V6 PA-YP AYVES AAEKH
V2 SLRAD QCKFL RWHTA V7 SPHEE CLT-Y NNRPW
V3 SVEPS LKMLG IYQAT V8 KVDTR RHGQL CLHPT
V4 VTRSG SGSDS NIIST V9 ------ ----- AI-DN
V5 SHN-L SRQWQ VDATQ V10 YIPLF GTIRA TCWLH
- no alteration of amino acid at that position
Y. YANG et al.: Protein Primary Structure and Soluble Expression Level
January-March 2018 | Vol. 56 | No. 1 104
Tween 20 (PBST; Shanghai Hushi Laboratorial Equipment Co. 
Ltd), the dAbs were detected using HRP-labelled protein A 
(Boster Biological Technology Co. Ltd., Beijing, PR China) with 
the substrate tetramethylbenzidine (Zhengzhou Biocell Bi-
otechnology Co. Ltd., Zhengzhou, PR China). The reactions 
were stopped by the addition of 100 μL of 2 M sulfuric acid, 
and the absorbance was measured at 450 nm/620 nm using 
an EZ Read 800 (Biochrom, Cambridge, UK). The amount of 
dAb was calculated from a standard curve made using refer-
ence sample. Total protein mass fraction was detected using a 
modified Bradford protein assay kit (Sangon Biotech Co. Ltd., 
Shanghai, PR China). To avoid the difference caused by differ-
ent degrees of cell lysis, standardized amounts of dAbs in μg 
per g of total protein were calculated as follows and used in 
the data analysis (Table 2): 
 w(total protein)=m(dAb)/m(total protein)  /2/
Data analysis
The software package R (24) was used to analyze the 
contributions of factors such as AA composition, dAb 
charge and polarity on dAb soluble expression level. Fac-
tors with p<0.05 were considered significant. Categories of 
AAs based on Vector NTI® (25) are listed in Table 3. Two lev-
els of analysis were run, including dividing expression lev-
els into high and low by Clustal Omega (26), and identify-
ing the factors that had an effect on the expression level by 
t-test. A linear regression model was constructed, then fac-
tors that had a significant influence were removed in turn 
to identify the most significant ones based on Akaike infor-
mation criterion (AIC) values (27). We used SWISS-MODEL 
(20) to get 3D structure, and PyMOL (21) to decorate CDRs 
in three different colours.
Table 2. Soluble expression data of 65 domain antibody (dAbs) variants using clustering and linear modelling
No. γ(soluble dAb in supernatant)/(ng/μL) γ(soluble dAb in pellet)/(ng/μL) γ(total soluble dAb)/(ng/μL)
1 3.3±0.4 4.3±0.7 3.5±0.2
2 3.6±0.6 5.0±0.3 3.9±0.5
3 4.0±0.8 4.2±0.2 4.0±0.6
4 4.0±0.8 4.3±0.4 4.1±0.6
5 5.0±1.1 3.8±0.2 4.6±0.7
8 3.6±0.3 2.3±0.3 3.1±0.3
9 3.4±0.5 4.3±1.0 3.6±0.6
10 3.2±0.4 4.5±0.8 3.5±0.4
11 3.2±0.3 3.1±0.9 3.1±0.5
13 3.5±0.7 4.5±1.1 3.7±0.8
15 3.4±0.6 2.5±0.5 3.0±0.5
17 5.6±0.5 4.2±1.1 5.0±0.4
19 3.7±0.2 4.0±1.0 3.8±0.4
20 3.7±0.6 3.1±0.6 3.5±0.5
21 4.7±0.8 2.9±0.4 4.1±0.7
22 1.1±0.3 1.2±0.2 1.1±0.2
24 2.8±0.6 4.9±1.0 3.2±0.6
26 4.8±1.2 3.0±0.4 4.3±0.9
27 3.7±0.4 1.9±0.2 2.9±0.1
28 3.8±0.8 3.3±0.8 3.6±0.5
29 4.5±0.1 2.4±0.7 3.8±0.5
32 3.5±0.7 4.3±1.2 3.7±0.7
34 0.6±0.1 0.8±0.1 0.7±0.0
35 3.3±0.4 1.3±0.3 2.6±0.3
37 3.5±0.6 3.8±0.3 3.6±0.4
38 4.7±0.5 4.2±0.9 4.5±0.6
39 2.7±0.7 2.3±0.6 2.5±0.3
41 4.8±0.3 4.6±0.9 4.8±0.3
42 0.8±0.1 0.5±0.1 0.6±0.1
43 3.1±0.6 3.2±0.5 3.1±0.5
44 5.8±1.0 3.4±0.5 5.0±0.4
45 4.4±0.3 1.2±0.2 3.1±0.2
46 3.7±0.6 2.4±0.5 3.2±0.4
47 4.8±1.3 2.5±0.5 4.1±1.0
48 3.4±0.5 3.3±0.9 3.3±0.5
49 3.8±0.5 2.3±0.7 3.2±0.4
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RESULTS
AA composition significantly affects the soluble expression 
of dAbs
It is widely accepted that AA sequence is significantly 
correlated with protein production, which was also shown in 
this study through analysis of the consistency of cluster re-
sults based on AA sequences and the corresponding soluble 
expression levels of dAbs (Table 4). AA compositions of the 
whole dAb (in percentage) were set as variables to explore 
No. γ(soluble dAb in supernatant)/(ng/μL) γ(soluble dAb in pellet)/(ng/μL) γ(total soluble dAb)/(ng/μL)
50 4.2±0.7 3.8±1.1 4.1±0.1
53 4.3±0.9 3.1±0.6 3.9±0.3
54 4.2±0.9 1.8±0.4 3.5±0.8
56 3.7±0.8 2.0±0.7 3.1±0.8
57 3.1±0.3 2.4±0.3 2.8±0.2
58 4.1±0.8 2.5±0.7 3.6±0.5
59 3.4±0.6 1.8±0.5 2.7±0.4
60 4.5±0.5 3.9±1.3 4.3±0.3
62 2.1±0.3 1.4±0.1 1.8±0.1
63 4.5±0.7 3.2±0.4 4.1±0.6
66 2.9±0.2 2.7±0.4 2.8±0.2
67 4.8±0.9 2.8±0.5 4.1±0.8
68 5.0±0.7 3.1±0.6 4.4±0.3
70 0.9±0.1 1.3±0.2 1.1±0.1
71 4.5±0.1 3.8±0.6 4.3±0.2
72 2.7±0.4 1.5±0.2 2.4±0.2
73 1.0±0.2 1.2±0.0 1.1±0.1
74 3.6±0.5 2.0±0.4 3.1±0.4
78 5.9±0.9 4.0±0.2 5.4±0.6
80 5.5±0.9 3.2±0.5 4.8±0.8
81 1.4±0.3 1.3±0.3 1.4±0.3
82 3.6±0.6 4.0±0.1 3.7±0.4
83 4.5±0.9 3.3±0.7 4.2±0.7
85 3.9±0.9 3.6±0.5 3.8±0.8
87 2.9±0.4 2.6±0.7 2.8±0.4
90 3.0±0.3 2.9±0.2 3.0±0.2
91 4.2±0.9 2.2±0.2 3.4±0.5
93 5.0±0.6 3.1±0.8 4.4±0.3
94 3.6±0.7 2.4±0.3 3.1±0.5
Soluble expression of dAb in validation strains
98 1.5±0.2 3.3±0.3 2.5±0.3
99 3.1±0.2 3.5±0.3 3.3±0.2
101 3.1±0.2 3.3±0.5 3.2±0.1
102 3.2±0.4 3.5±0.3 3.4±0.3
104 3.8±0.5 2.9±0.5 3.4±0.0
105 3.1±0.2 4.0±0.8 3.5±0.4
107 2.7±0.3 2.9±0.7 2.8±0.1
108 3.0±0.2 3.0±0.3 2.8±0.1
109 1.1±0.3 3.2±0.3 2.2±0.1
110 3.7±0.5 2.7±0.5 3.2±0.3
Results are expressed as mean value±standard deviation
Table 3. Category of amino acids based on Vector NTI® (25)
Category Amino acid
Charged R, K, D, C, H, Y, E
Polar N, T, C, G, Q, S, Y
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their effect on the dAb soluble expression level by a stepwise 
regression analysis, and the results are summarized in Table 5.
Stepwise regression was taken to analyse AA effect on 
dAb soluble expression level in broth supernatant, in pellet 
lysate supernatant and total soluble dAb. Results showed that 
the combination of AAs S, R, N, D, Q, Y, F and G had a signifi-
cant influence on dAb soluble yield in broth supernatant, with 
the p-value of 0.002. Specifically, S, N, D and Q had positive ef-
fects, with p-values of 0.0006, 0.02, 0.03 and 0.05, respectively, 
which means that the soluble yield of dAb in broth superna-
tant increased with increasing content of these AAs. However, 
R had a negative effect (p=0.001), thus dAb would be more 
difficult to express in soluble form in broth supernatant with 
a higher content of R. Moreover, the combined composition 
of  G, R, C, N, S, Y, K and A had a significant effect on dAb solu-
ble yield in the pellet lysate (p=0.002). Again, R showed a sig-
nificantly negative effect on the soluble expression (p=0.02), 
while G, C, N and S showed significantly positive effects, with 
p-values of 0.01, 0.02, 0.03 and 0.03, respectively. When ana-
lyzing AA effect on total amount of soluble dAb, the com-
bined composition of R, S, G, N, Y, C, Q and F showed a signif-
icant influence (p=0.0007). The most significant AAs were R 
(negative), S (positive) and G (positive), for which the p-values 
were 0.0008, 0.006 and 0.03, respectively (Table 2). Additional-
ly, stepwise regression analysis of the features of the dAbs, in-
cluding charge, polarity, hydrophobicity, acidity and alkalinity, 
Table 4. Clustering results based on amino acid sequences and soluble expression amounts
No. Expresionlevel Seq. Consist. No.
Expresion
level Seq. Consist. No.
Expresion
level Seq. Consist.
1 1 1 + 34 2 2 + 62 2 1 –
2 1 1 + 35 2 2 + 63 1 1 +
3 1 1 + 37 1 1 + 66 2 2 +
4 1 1 + 38 1 1 + 67 1 1 +
5 1 1 + 39 2 1 – 68 1 1 +
8 2 2 + 41 1 2 – 70 2 2 +
9 1 1 + 42 2 2 + 71 1 1 +
10 1 1 + 43 1 1 + 72 2 2 +
11 1 2 – 44 1 1 + 73 2 2 +
13 1 1 + 45 2 1 – 74 2 2 +
15 2 1 – 46 2 2 + 78 1 1 +
17 1 2 – 47 1 2 – 80 1 1 +
19 1 1 + 48 1 2 – 81 2 1 –
20 1 1 + 49 2 2 + 82 1 1 +
21 1 1 + 50 1 1 + 83 1 1 +
22 2 2 + 53 1 1 + 85 1 1 +
24 1 1 + 54 2 1 – 87 2 1 –
26 1 1 + 56 2 1 – 90 1 1 +
27 2 2 + 57 2 2 + 91 1 2 –
28 1 2 – 58 1 2 – 93 1 1 +
29 1 2 – 59 2 2 + 94 2 1 –
32 1 2 – 60 1 1 + Ori 2 1 –
1 and 2=cluster result of groups 1 and 2 respectively, based on expression levels or sequences of domain antibodies, + and –=consistency and 
inconsistency of these two cluster results respectively
Table 5. Amino acids (AAs) that have significantly effect on soluble expression levels of human serum albumin (HSA) domain antibody (dAb)







R – R – S +
C + N + G +
N + D + N /
S + Q + Y /
Y / Y / C /
K / F / Q /
A / G / F /
+=positively/negatively correlated, –=negatively correlated, /=no correlation
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showed that polarity was the most important feature that had 
a positive influence on dAb soluble yield (p=0.02).




where y indicates the soluble expression score in %, R is argi-
nine, F is phenylalanine, G is glicine, S is serine, C is cysteine, 
Q is glutamine, Y is tyrosine and N is asparagine.
The higher the score, the higher the soluble expression 
level of dAb. Clustering results divided the sequences of the 
65 experimental subjects and the control dAb into high- and 
low-expression groups; the score distribution is shown in Fig. 
2. Twenty out of 25 dAbs belonging to the low-expression 
group had a score <2.5, while 31 out of 41 high-expression 
dAbs had a score >2.5. We conclude that dAbs with a score 
<2.5 are likely to be expressed at a low level in soluble form 
and the soluble yield would possibly be <(2.4±0.9) μg/g. On 
the other hand, dAbs with a score >2.5 are likely to be ex-
pressed at a high level in soluble form, with the potential sol-
uble yield higher than (4.0±0.5) μg/g.
Verification
Using the same cultivation and detection methods as in 
the experiments above, expression data were obtained for 10 
verification subjects and a control. Comparing the predicted 
expression levels from the model with the actual soluble yield 
of these dAbs, the accuracy of the prediction model was 80 
% (Table 6).
DISCUSSION
Since 1990 there have been many researches exploring 
the correlation between protein sequence and expression lev-
el; however, no consensus has been reached. For example, 
one project studied 81 different human proteins and came to 
the conclusion that increasing the average charge, decreas-
ing the number of turn-forming AAs, or decreasing the con-
tent of cysteine could reduce the amount of inclusion bod-
ies (10), while another studied G-protein-coupled receptors 
and found that increasing the positive charge encouraged the 
formation of inclusion bodies (11). Goh et al. (28) discovered 
that high hydrophobicity was a disadvantage for expressing 
proteins in soluble form by analyzing 27 267 proteins select-
ed from TargetDB, whereas Luan et al. (29) expressed 10 167 
ORFs of Caenorhabditis elegans using a robotic pipeline and 
found that hydrophobicity was not linearly correlated with 
the soluble expression level of protein, but proteins with low-
er hydrophobicity displayed higher levels of soluble expres-
sion. These works proved that studies using different subjects 
could come to different or even opposite conclusions. Here, 
to avoid the influence of protein properties including molec-
ular mass, length and complex structures, expression system 
used, or operation bias, first we used dAb as the experimental 
subject, because this protein has low molecular mass, concen-
trated regions of variation, is easy to express in E. coli and has 
a simple tertiary structure. Second, 15 AA mutated in CDRs 
guaranteed enough variation among dAbs and little variation 
in pI, molecular mass and length, which helped us to focus on 
the variable of AA composition. Furthermore, we used consist-
ent cultivation conditions and detection methodology to col-
lect data, and repeated the process three times with constant 
control strain, which guaranteed the parallelity of operation.
Table 6. Comparison between predicted and factual soluble yield of of human serum albumin (HSA) domain antibody (dAb)




V1 0.5 Low 2.5 Low Yes
V2 0.8 Low 3.3 Low Yes
V3 3.1 High 3.2 Low No
V4 3.9 High 3.4 High Yes
V5 2.6 High 3.4 High Yes
V6 2.2 Low 3.4 High No
V7 2.1 Low 2.8 Low Yes
V8 1.1 Low 2.8 Low Yes
V9 1.5 Low 2.2 Low Yes


















Fig. 2. Score statistics of 66 domain antibodies (dAbs). Twenty out of 
25 dAbs belonging to the low-expression group had a score <2.5, 
while 31 out of 41 high-expression dAbs had a score >2.5
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We found that polarity had a significantly positive influ-
ence on dAb soluble yield. In other words, the total content 
of N, S, C, G, T, Q and Y positively correlated with dAb soluble 
yield. This may be because in this small protein there is a high 
likelihood of exposure to solvent of polar AAs after folding, 
which enhances the solubility of the protein through protein–
solvent interaction, thus indirectly increasing the soluble ex-
pression level of the protein (30).
We discovered that arginine content had a significantly 
negative correlation with dAb soluble yield, consistent with a 
report that positively charged AAs could hinder the process of 
translation, thus bringing down the expression level (7). Step-
wise regression analysis showed that the glycine content was 
positively correlated with dAb soluble yield, which may be at-
tributable to the small molecular mass and polarity of G. The 
significantly positive influence of S supports the conclusion 
that polar AAs benefit dAb soluble expression. We suggest 
that increasing the total content of G and S, or decreasing the 
content of R is helpful to improve the soluble expression level 
of dAb. Findings from this study may act as a general guide for 
site-directed mutagenesis of HSA dAbs or other similar dAbs/
Abs to improve the soluble expression levels, which benefits 
further studies such as interaction mechanism and structure 
research. Furthermore, considering the attractive advantages 
of E. coli as a protein expression host, our preliminary observa-
tions pave the way towards establishing more efficient E. coli 
expression strategies for desired proteins.
CONCLUSION
Certain amino acids (AAs) significantly affected the sol-
uble expression level of domain antibody (dAb) in the broth 
supernatant and in the pellet lysate, and total soluble dAb, 
with the specific AA combinations being (S, R, N, D, Q), (G, R, 
C, N, S) and (R, S, G). R displayed a negative influence, where-
as G and S showed positive effects. Increasing the content of 
polar AAs, especially G and S, and decreasing the content of 
R was helpful to improve the soluble expression level of hu-
man serum albumin (HSA) dAb. This linear model had a pre-
diction accuracy of 80 %. 
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